PuraMed reveals study results via social media; Instem gulps BioWisdom to speed reports;

> PuraMed BioScience will release clinical study results in the social media rollout of LipiGesic M, a migraine treatment. PuraMed release

> Instem--a provider of business intelligence, workflow management, document management and report compilation applications--has taken over BioWisdom, a provider of solutions that speed access to scientific information. Item

> Tissue imaging systems maker Caliper Life Sciences and HistoRx, an image-analysis systems maker, are co-developing immunofluorescence-based solutions for the analysis of proteins in tissue samples. Article

> There is no clear plan or leadership for the advancement of personalized medicine, particularly in the clinical trials area, says Sir Gordon Duff, chairman of the UK's Commission on Human Medicines. Story

> A Ponemon Institute study finds that data breach victims often move too quickly, wasting lots of money and losing customers unnecessarily. Article

> Forest Laboratories and the Allergy Asthma Research Institute have joined the SAFE-BioPharma Association, adopting the digital identity and signature standard. SAFE release

> CDISC, the Clinical Data Interchange Standards Consortium, welcomes three directors to its board: Robert DiLaura, former bioinformatics co-director at Case Western Reserve University and Cleveland Clinic; Eliot Siegel, vice chair for information systems at the University of Maryland School of Medicine; and Kiyoteru Takenouchi, corporate officer for e-clinical business at CMIC Co. CDISC release

> A psychiatrist finds that funding sources and conflicts of interests in randomized controlled pharma trials are rarely reported when the data is combined into a meta-analysis. Story

> E-clinical solutions provider DATATRAK has been given its first assignment by Indian CRO Kreara, a Phase II study for a dermatology product. Datatrak release

> BJC Healthcare and Washington University are using IBM software to extract data from more than 50 million documents in medical records. IBM release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.